Evidence map›Paper›PMID 27724879›Full record

ArticleBMC psychiatry2016

Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England.

Lamiece Hassan, Jane Senior, Roger T Webb, Martin Frisher, Mary P Tully, David While, Jenny J Shaw

Open access · goldAbstract read
In one paragraph

Article in BMC psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exploring Polypharmacy in the BC Correctional Health Setting.The Canadian journal of hospital pharmacy · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Marketing Antipsychotics to Correctional Facilities: A Review of Pharmaceutical Industry Documents.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lamiece HassanFaculty for Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK. lamiece.hassan@manchester.ac.uk.
Jane SeniorFaculty for Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Roger T WebbFaculty for Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Martin FrisherSchool of Pharmacy, Keele University, Hornbeam Building, Keele, Staffordshire, ST5 5BG, UK.
Mary P TullyThe Manchester Pharmacy School, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
David WhileFaculty for Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Jenny J ShawFaculty for Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
University of Manchester · GBKeele University · GB

Funding

Department of Health 10/2002/03
6 · The paper itself

Abstract

backgroundMental illness is highly prevalent among prisoners. Although psychotropic medicines can ameliorate symptoms of mental illness, prescribers in prisons must balance clinical needs against risks to safety and security. Concerns have been raised at the large number of prisoners reportedly receiving psychotropic medicines in England. Nonetheless, unlike for the wider community, robust prescribing data are not routinely available for prisons. We investigated gender-specific patterns in the prevalence and appropriateness of psychotropic prescribing in English prisons.

methodsWe studied 6052 men and 785 women in 11 prisons throughout England. This represented 7.9 % of male and 20.5 % of female prisoners nationally. Using a cross-sectional design, demographic and prescription data were collected from clinical records of all prisoners prescribed psychotropic medicines, including hypnotic, anxiolytic, antipsychotic, anti-manic, antidepressant and Central Nervous System stimulant medications. Percentages and 95 % CIs were used to estimate the prevalence of prescribing. The Prescribing Appropriate Indicators tool was used to determine appropriateness. Prevalence Ratios (PR) were generated to make age-adjusted comparisons between prisoners and the general population using a dataset supplied by the Clinical Practice Research Datalink.

resultsOverall, 47.9 % (CI 44.4-51.4) of women and 16.9 % (CI 16.0-17.9) of men in prison were prescribed one or more psychotropic medicines. Compared with the general population, age-adjusted prescribing prevalence was six times higher among women (PR 5.95 CI 5.36-6.61) and four times higher among men (PR 4.02 CI 3.75-4.30). Undocumented or unapproved indications for prescriptions, not listed in the British National Formulary, were recorded in a third (34.7 %, CI 32.5-37.0) of cases, most commonly low mood and personality disorder.

conclusionsPsychotropic medicines were prescribed frequently in prisons, especially among women, and for a wider range of indications than are currently recommended. These findings raise questions about whether the prescribing of psychotropic medicines in prisons is wholly appropriate and proportionate to the level of clinical need. Prisons need to develop a wider array of treatment responses, other than medicines, to effectively tackle mental illness, challenging behaviours and distress.

Indexed as

PrisonsAdultAnti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsCross-Sectional StudiesDrug PrescriptionsEnglandFemaleHumansHypnotics and SedativesMaleMental DisordersMiddle AgedPrevalencePrisonersAnti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsHypnotics and SedativesPsychotropic DrugsAntidepressantsAntipsychoticsGenderMental illnessPrescribingPrisonPsychotropic

Identifiers

PMID27724879
PMCPMC5057241
OpenAlexW2531138828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.